D-Amphetamine Boosts Language Learning Independent of its Cardiovascular and Motor Arousing Effects
暂无分享,去创建一个
Pienie Zwitserlood | Caterina Breitenstein | Stefan Knecht | Sandra Kamping | Stefanie Wailke | E. Ringelstein | S. Knecht | C. Breitenstein | P. Zwitserlood | S. Kamping | S. Bushuven | S. Wailke | E Bernd Ringelstein | Stefan Bushuven | E. Ringelstein
[1] M. Devous,et al. A Double-Blind, Placebo-Controlled Study of the Use of Amphetamine in the Treatment of Aphasia , 2001, Stroke.
[2] R. Teasell,et al. Rehabilitation of Aphasia: More Is Better , 2003, Topics in stroke rehabilitation.
[3] Jonathan D. Cohen,et al. Dopamine and the mechanisms of cognition: Part II. D-amphetamine effects in human subjects performing a selective attention task , 1998, Biological Psychiatry.
[4] James N. Davis,et al. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients , 1988, Annals of neurology.
[5] D. Walker-Batson,et al. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. , 1995, Stroke.
[6] F. Müller,et al. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study , 2001, The Lancet.
[7] C. Montigny,et al. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments , 1997, Brain Research Reviews.
[8] D. M. Feeney,et al. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. , 1982, Science.
[9] D. Hovda,et al. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat , 1984, Brain Research.
[10] R. C. Oldfield. The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.
[11] K. Ressler,et al. Role of norepinephrine in the pathophysiology and treatment of mood disorders , 1999, Biological Psychiatry.
[12] Richard Coppola,et al. Effects of Dextroamphetamine on Cognitive Performance and Cortical Activation , 2000, NeuroImage.
[13] S. Wiebe. Seizure Control as an Indicator of Therapeutic Usefulness , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[14] K. Ressler,et al. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.
[15] Paola Marangolo,et al. Acquisition of New “Words” in Normal Subjects: A Suggestion for the Treatment of Anomia , 2001, Brain and Language.
[16] Klaus P. Ebmeier,et al. The effects of noradrenergic re-uptake inhibition on memory encoding in man , 2001, Psychopharmacology.
[17] P. Groves,et al. Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. , 1976, Annual review of psychology.
[18] S. Hesse,et al. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study , 2003, Clinical rehabilitation.
[19] J. Davis,et al. Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat. , 1990, Restorative neurology and neuroscience.
[20] Giuseppe Esposito,et al. Dextroamphetamine Enhances “Neural Network-Specific” Physiological Signals: A Positron-Emission Tomography rCBF Study , 1996, The Journal of Neuroscience.
[21] R. D'Hooge,et al. Effect of amphetamine on long-term retention of verbal material , 1995, Psychopharmacology.
[22] S. Haber,et al. Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] D. Walker-Batson. Use of Pharmacotherapy in the Treatment of Aphasia , 2000, Brain and Language.
[24] B. Rockstroh,et al. Constraint-Induced Therapy of Chronic Aphasia After Stroke , 2001, Stroke.
[25] M. Deanna. Pharmacological manipulation of human working memory , 2004 .
[26] E. Ringelstein,et al. Levodopa: Faster and better word learning in normal humans , 2004, Annals of neurology.
[27] N. Wahlgren,et al. Safety of Dexamphetamine in Acute Ischemic Stroke: A Randomized, Double-Blind, Controlled Dose-Escalation Trial , 2003, Stroke.
[28] M. Viitanen,et al. A Double-Blind Placebo-Controlled Study of the Effects of Amphetamine and Physiotherapy after Stroke , 2001, Cerebrovascular Diseases.
[29] R. D'Hooge,et al. Amphetamine enhances human-memory consolidation , 1993, Neuroscience Letters.
[30] J. Kulisevsky,et al. Role of Dopamine in Learning and Memory , 2000, Drugs & aging.
[31] L. Goldstein. Influence of common drugs and related factors on stroke outcome , 1997, Current opinion in neurology.
[32] C. A. Morgan,et al. Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans. , 2002, The American journal of psychiatry.
[33] A. Basso,et al. Aphasia Therapy or The importance of being earnest , 2001 .
[34] L. Kalra,et al. Racial inequity of access to carotid imaging. , 1999, Stroke.
[35] DelainaWalker-Batson,et al. Amphetamine Paired With Physical Therapy Accelerates Motor Recovery After Stroke , 1995 .
[36] D. Barch. Pharmacological manipulation of human working memory , 2003, Psychopharmacology.
[37] D. M. Feeney,et al. α-Noradrenergic agonists and antagonists affect recovery and maintenance of beam-walking ability after sensorimotor cortex ablation in the rat. , 1992, Restorative neurology and neuroscience.
[38] D. M. Feeney,et al. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury , 1990, Pharmacology Biochemistry and Behavior.
[39] D. Walker-Batson,et al. A Double-Blind, Placebo-Controlled Study of the Use of Amphetamine in the Treatment of Aphasia , 2001, Stroke.
[40] J. D. McGaugh,et al. Role of the Basolateral Amygdala in Memory Consolidation , 2003, Annals of the New York Academy of Sciences.
[41] L. Goldstein,et al. Amphetamine-facilitated poststroke recovery. , 1999, Stroke.
[42] L. Goldstein. Amphetamines and related drugs in motor recovery after stroke. , 2003, Physical medicine and rehabilitation clinics of North America.
[43] S. Eksborg,et al. Drugs for Stroke Recovery , 2004, Drugs & aging.
[44] Caterina Breitenstein,et al. Development and validation of a language learning model for behavioral and functional-imaging studies , 2002, Journal of Neuroscience Methods.
[45] D. Gladstone,et al. Enhancing Recovery after Stroke with Noradrenergic Pharmacotherapy: A New Frontier? , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[46] Sylvain Houle,et al. Oral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET , 2004, Synapse.
[47] R. Teasell,et al. Intensity of Aphasia Therapy, Impact on Recovery , 2003, Stroke.
[48] J. Nutt,et al. Pharmacokinetics of levodopa. , 1984, Clinical neuropharmacology.
[49] Paul E Kinahan,et al. PET Measures of Amphetamine-Induced Dopamine Release in Ventral versus Dorsal Striatum , 1999, Neuropsychopharmacology.
[50] Robert S. Pinals,et al. A double‐blind, placebo‐controlled trial , 1986 .
[51] Robert B. Innis,et al. Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naı̈ve healthy volunteers: results from a large cohort , 2003, European Neuropsychopharmacology.
[52] D. Hovda,et al. Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation , 1985, Brain Research.
[53] Carl-Walter Kohlmann,et al. Untersuchungen mit einer deutschen Version der "Positive and Negative Affect Schedule" (PANAS). , 1996 .
[54] N. Schneiderman,et al. Amphetamine promotes recovery from sensory-motor integration deficit after thrombotic infarction of the primary somatosensory rat cortex. , 1991, Stroke.
[55] R. R. Robey. The Efficacy of Treatment for Aphasic Persons: A Meta-analysis , 1994, Brain and Language.
[56] C. Breitenstein,et al. Spracherwerb und statistisches Lernen , 2003, Der Nervenarzt.
[57] D. Watson,et al. Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.
[58] M. Egan,et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine , 2003, Proceedings of the National Academy of Sciences of the United States of America.